Updated hourlyHourly refreshWed, Oct 28, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare · Education
EDMONTON, AB, Aug. 23, 2026 -- The 2026 CPKC Women's Open raised a record $4.95 million to support heart healthcare in Alberta, while on the golf course, Miyu Yamashita concluded a historic performance on Sunday to capture the 2026 CPKC Women's Open and her fourth LPGA Tour...
Aug 24 · 02:49·PR Newswire
Healthcare · Biotech & pharma
SHANGHAI and HONG KONG, Aug. 23, 2026 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
Aug 24 · 01:00·PR Newswire
Healthcare · Education
TAIPEI, Aug. 23, 2026 -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that it has entered into a Collaborative Research Agreement (CRA) with the Laboratory of Veterinary Surgery, Graduate...
Aug 24 · 00:00·PR Newswire
AI · Healthcare
BANGKOK, August 24, 2026--InterSystems, a creative data technology provider managing over one billion healthcare records globally, will bring healthcare leaders from across Asia to Bangkok for InterSystems Asia READY 2026, where the focus will be on how trusted data, interoperability, and practical artificial intelligence (AI) can accelerate smarter healthcare delivery and strengthen Thailand's position as a regional medical hub.
Aug 24 · 00:00·Business Wire
Healthcare
SAN JOSE, Calif., August 24, 2026--Shape Memory Medical Inc., developer of proprietary shape memory polymer technology for endovascular embolization, today announced the closing of a $10 million convertible note financing led by new investor August Global Partners (AGP), joined by fellow new investor Taiwania Capital.
Aug 24 · 00:00·Business Wire
Healthcare · Biotech & pharma
SINGAPORE, August 23, 2026--Novotech, a leading global biotech full service CRO, has strengthened its established presence in Japan with the opening of a new office in Tokyo.
Aug 23 · 23:01·Business Wire
Healthcare · Biotech & pharma
Orum receives FDA clearance for ORM-1153, advancing its novel CD123-GSPT1 degrader-antibody conjugate toward Phase 1 in hematologic malignancies.
Aug 23 · 00:00·GlobeNewswire
Healthcare · Education
ROSEMONT, Ill., Aug. 22, 2026 -- The American Association of Nurse Anesthesiology (AANA) today announced the launch of Anesthesia Answers, a new patient education resource created by Certified Registered Nurse Anesthetists (CRNAs)/nurse anesthesiologists to help patients and...
Aug 22 · 13:03·PR Newswire
Finance · Healthcare
DUBAI, United Arab Emirates and NEW YORK, Aug. 22, 2026 -- SuperiorMed Holdings Limited, a Cayman Islands company (“SuperiorMed” or the “Company”), a company that shall become the parent company of SuperiorMed Healthcare Management FZ-LLC, a company in the business of management and consulting service for certain medical institutions under the laws of the United Arab Emirates (“UAE”), announced today that it has entered into an Agreement and Plan of Merger (the “Merger Agreement”) on August 22, 2026 for a business combination with Starry Sea Acquisition Corp (Nasdaq: SSEA, SSEAU, SSEAR), a special purpose acquisition company incorporated in the Cayman Islands (“SSEA”).
Aug 22 · 05:24·GlobeNewswire
Finance · Healthcare
HENDERSON, Nev., August 21, 2026--Zura Bio Limited (Nasdaq: ZURA) ("Zura" or the "Company"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today reported that on August 20, 2026, the Company granted inducement awards consisting of options to purchase up to 587,000 Class A Ordinary Shares (the "Options") to thirteen newly hired employees. These a
Aug 21 · 23:57·Business Wire
Finance · Healthcare
San Francisco, California--(August 21, 2026) - Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations concerning a Phase 3 clinical trial of a therapy intended to treat patients with melanoma.The news that the trial failed drove the price of Regeneron shares sharply lower and, along with the severe market reaction ($11 billion market cap wipeout),...
Aug 21 · 21:47·Newsfile
Healthcare · Industrial
Memodyne's supplement label, USA manufacturing, and brain health category context are outlined for daily wellness comparison shoppers.
Aug 21 · 21:39·GlobeNewswire